Evonik buy fermentative methionine production technology from METEX

Evonik to buy fermentative methionine production technology from METEX

6:23 AM, 29th November 2016

ESSEN, GERMANY/CLERMONT-FERRAND, FRANCE: Evonik Industries AG has agreed to buy a technology package from METabolic EXplorer (METEX), strengthening its biotechnology platform for amino acids.

The package includes METEX’s entire technology portfolio for the fermentative production of methionine, as well as patents, essential bacteria strains, and the inoLa brand. METEX considers that this agreement will highlight the relevance of its substitute technologies and will reinforce its ability to commercialise its other technologies.

The deal also includes a back-license agreement relating to certain patents to be transferred to Evonik; this contract will allow METEX to continue using these patents for activities other than those relating to methionine. Moreover, the companies mean to explore the possibility of an R&D collaboration agreement on the development of biotechnologically produced amino acids.

The total consideration for the transfer of this technology, including a two-year transfer service agreement, amounts to €45 million.

Amino acids produced by fermentation are an important pillar of Evonik’s product portfolio for sustainable animal nutrition. Production process efficiency for Biolys (lysine), ThreAMINO (threonine) and TrypAMINO (tryptophane) has been continuously improved over the past few years, and the portfolio was recently expanded to include ValAMINO (valine).

“Through its fermentative methionine production process, METEX has demonstrated excellent development work and was able to secure wide-ranging patent protection. The acquisition of this technology will expand our technological leadership for amino acids produced both chemically and by fermentation,” said Dr Emmanuel Auer, head of Evonik’s animal nutrition business line.

“We have been able to show that the fermentation process for manufacturing methionine is a potential alternative to familiar manufacturing routes. The technology will be transferred to Evonik immediately after the required approval of Evonik committees. This is expected before mid-December 2016,” said Benjamin Gonzalez, CEO of METEX.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Mexichem acquires PVC compounds manufacturer in UK

TLALNEPANTLA, US: Mexichem said that it has purchased a leading UK-based technical (polyvinyl chloride) PVC compounds manufacturer, Vinyl Compounds Ho ...

Read more
Sasol unveils polypropylene expansion project in South Africa

SECUNDA, SOUTH AFRICA: Sasol Limited completes another major capital investment in South Africa as part of its dual-regional, multi-asset hub growth s ...

Read more
Different facets of silicones

The next gen automotive will be governed by low weight, high strength materials and silicones fit the bill. More and more automotive manufacturers are ...

Read more
Kemira CEO named as chairman of Chemical Industry Federation of Finland

HELSINKI, FINLAND: Kemira Oyj said that its president and CEO, Jari Rosendal has been elected as the chairman of Chemical Industry Federation of ...

Read more
The musky fragrance of the west; The spicy flavour of the east

Editorial of Chemical Today magazine. Recently on a lazy, sunny weekend, I met up with a friend in a neighbourhood cafe. Over drinks of watermelon ...

Read more
Johnson & Johnson in talks to buy Europe's drugmaker Actelion

NEW BRUNSWICK, US: Johnson & Johnson (JNJ) confirmed that it is engaged in preliminary discussions with Actelion Pharmaceuticals Ltd (ATLN) regard ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X